TMO · NYSE · Healthcare · Diagnostics and Research
$700.19+0.1%Nov 13 close
Figures through September 26, 2026, from the 10-Q filed October 30, 2026
Thermo Fisher sells laboratory supplies, scientific instruments, diagnostic tests, and services for developing and making medicines.
The quarter ending September 26, 2026, against the same quarter a year earlier.
| Measure | 3 months toSep 26, 2026 | 3 months toSep 27, 2025 | Change |
|---|---|---|---|
| Total Revenue | $12.1B | $11.1B | +9.13% |
| Profit | $1.7B | $1.6B | +6.50% |
| Profit per share | $4.64 | $4.27 | +8.67% |
| Free Cash Flow | $2.1B | $1.8B | +15.15% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
A short summary of each call — what the quarter showed, what management expects and whether they delivered on what they said last time — with the full transcript underneath.
“We are very pleased to deliver another excellent quarter, with outstanding financial performance on both the top and bottom line,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Thermo Fisher Scientific Inc.’s Item 2.02 8-K filed October 21, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.
Source: Yahoo Finance, transcribed by Quartr. Speaker names and roles are as transcribed; analysts are sometimes unnamed.
Call summaries are part of Pro
A two-minute read of every Thermo Fisher Scientific Inc. earnings call: the numbers that mattered, what management expects, whether they delivered on last quarter’s outlook, and what analysts asked that went unanswered.
See one first on , , , or — open to everyone.
Summaries of earlier calls are part of Pro.
Summaries of earlier calls are part of Pro.